Daiichi Sankyo US
Buying intent
98 tracked signals | Top 15 topics are below | Marketing is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Daiichi Sankyo US's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
18d ago
20d ago
14d ago
18d ago
3d ago
18d ago
18d ago
17d ago
20d ago
18d ago
23d ago
18d ago
18d ago
29d ago
29d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Daiichi Sankyo US
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
31 people across every department at Daiichi Sankyo US, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileAt Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication. With more than 125+ years of experience, Daiichi Sankyo leverages its world-class science and technology to crea
New capability sought
Employee posts (LinkedIn)Future of Work; Leadership Development; Patient Safety; Project Management
Top accounts researching Daiichi Sankyo US
names withheld on the public pageThese are companies whose own people brought up Daiichi Sankyo US unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
151,426 companies · 839,012 people are researching Artificial Intelligence
Daiichi Sankyo US's own team shows 11 signals on this topic. No one outside Daiichi Sankyo US has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Hiring75,708 cos · 411,263 people
- Oncology1,930 cos · 6,417 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Marketing — 4 people; Leadership — 2 people; HR / Talent — 1 person; Sales — 1 person
What's been said
public posts by Daiichi Sankyo US's teamNo public post naming Daiichi Sankyo US has surfaced in the past year, so this is what Daiichi Sankyo US's own team is posting about publicly — their topics, in their words.
I’m pleased to share that I have recently been qualified and registered as an immigration advisor with the Immigration Advice Authority (IAA) With ongoing changes in UK immigration policy, many organisations are facing increasing challenges in attracting and retaining overseas talent while maintaining compliance. I’m passionate about supporting businesses that rely on international skills to not only navigate these complexities, but to continue to grow and thrive. I’m particularly interested in engaging with organisations across the energy, manufacturing, arts, and sports sectors to better understand current pressures and identify where effective immigration support can unlock sustainable growth. Collaboration is important to me, and I’m also keen to partner with charities and non-profit organisations who may need additional guidance in this space. If you’d like to connect or explore how we can work together, please feel free to reach out at Naseem@slspec.co.uk / Sponsor Licence Specialists
Apr 2026